Related Experiment Video
Updated: Aug 13, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
Published on: January 27, 2019
TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients
Sandra A Drigo1, Edecio Cunha-Neto, Bárbara Ianni
1Heart Institute (InCor), School of Medicine, University of São Paulo, Av. Dr. Enéas de Carvalho Aguiar 44, bloco 2, 9 andar, CEP: 05403-001 São Paulo, Brazil.
Insights
Genetic factors influence survival in Chronic Chagas' disease cardiomyopathy (CCC). Specific tumor necrosis factor (TNF) gene variations are linked to significantly reduced survival in severe CCC patients, impacting mortality predictions.
Area of Science:
- Cardiology
- Genetics
- Infectious Diseases
Background:
- Chronic Chagas' disease cardiomyopathy (CCC) is a severe complication of Trypanosoma cruzi infection, leading to heart failure and reduced survival.
- Genetic factors may explain differential survival rates among severe CCC patients.
- Tumor necrosis factor-alpha (TNF-alpha) is implicated in heart failure progression and is elevated in CCC patients.
Purpose of the Study:
- To investigate the role of tumor necrosis factor (TNF) gene polymorphisms as predictors of mortality in severe Chronic Chagas' disease cardiomyopathy (CCC).
Main Methods:
- Genotyping of the TNFa microsatellite and the -308 TNF promoter polymorphism in 42 severe CCC patients.
- Survival analysis using Cox proportional hazards model to assess the impact of TNF genotypes on mortality.
Main Results:
- The TNF genotype, specifically the TNF2 promoter allele or TNFa2 microsatellite allele, was identified as an independent predictor of mortality in severe CCC.
- Patients with TNF2 or TNFa2 alleles had significantly shorter median survival times (2.9 and 8 months, respectively) compared to other alleles (HR(adj)=2.28, p=0.020).
Conclusions:
- This study identifies a genetic factor (TNF genotype) associated with reduced survival in severe Chronic Chagas' disease cardiomyopathy.
- The findings suggest that TNF genotype should be considered in therapeutic planning for severe CCC patients to predict mortality risk.
Abstract:
Chronic Chagas' disease cardiomyopathy (CCC) is the most important clinical outcome of infection by the parasite Trypanosoma cruzi, affecting 18 million individuals in Latin America. One-third of CCC patients develop heart failure due to end-stage dilated cardiomyopathy, and their survival is reduced by 50% compared to patients with other cardiomyopathies. Genetic susceptibility may play a role in the differential survival of severe CCC patients. Given the role of TNF-alpha in the progression of heart failure, and the increased TNF-alpha plasma and heart tissue levels observed in these patients, we chose TNF as a candidate gene for increased mortality in severe CCC patients. We typed the TNFa microsatellite and the -308 TNF promoter polymorphism and then analyzed the survival curves of 42 patients with severe ventricular dysfunction (left ventricular ejection fraction
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
American Trypanosomiasis
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life